Moderna company (photo from the moderna company’s Facebook page)
The pharmaceutical manufacturer Moderna hopes to produce a new line of life-saving vaccines against cancer, heart disease and more by the year 2030. This is what the company stated yesterday (Monday).
Moderna’s chief medical officer, Dr. Paul Burton, told The Guardian he was confident these vaccines would be ready by the end of the decade, adding that Moderna could offer them in just five years. He noted that advances in RNA or mRNA technology, since the beginning The corona epidemic led to a “golden age” for new vaccines.
“I think what we’ve learned in the last few months is that if you ever thought that mRNA was just for infectious diseases, or just for coronavirus, the evidence now is that that’s absolutely not the case,” Burton told the Guardian. “It can be applied to all kinds of diseases; we are working on vaccines for cancer, infectious diseases, cardiovascular diseases, autoimmune diseases.
More in-
Studies of injections for those diseases have shown “tremendous promise,” he added. Burton’s comments come as Moderna navigates its post-coronavirus success, when the Cambridge, Mass.-based company became a household name for its RNA technology, which teaches human cells to make a protein that starts an immune response against disease.
Burton highlighted Moderna’s personalized cancer vaccine, a highly touted mRNA injection developed to target different tumor types. Barton told the Guardian the vaccine would be “highly effective” and “save hundreds of thousands, if not millions, of lives”.
Burton also highlighted the ability of RNA to tackle rare diseases for which treatments are not yet available. These mRNA therapies may be available a decade from now, he said. “I think we will have mRNA-based treatments for rare diseases that were previously untreatable, and I think that in 10 years from now, we will be approaching a world where you can actually identify the genetic cause of the disease, and relatively simply, treat it using mRNA-based technology,” he told The Guardian.
Comments to the article(0):
Your response has been received and will be published subject to the system policy.
Thanks.
for a new comment
Your response was not sent due to a communication problem, please try again.
Return to comment